Publications by authors named "Alba Rivas-Oural"
Management of immunosuppressive therapy in kidney transplant recipients with COVID-19. A multicentre national study derived from the Spanish Society of Nephrology COVID registry.
María O López-Oliva Isabel Pérez-Flores María Molina María José Aladrén Hernando Trujillo Alba Rivas-Oural
Nefrologia (Engl Ed)
November 2023
Article Synopsis
- The SARS-CoV-2 virus had a big effect on kidney transplant patients, making them more likely to get really sick, especially early in the pandemic.
- Doctors adjusted their medications to help manage COVID-19, which included reducing some immunosuppressive drugs that protect the kidney.
- A study looked at how these changes affected kidney health and certain antibodies in patients six months after they got COVID-19, finding that most patients’ kidney function stayed fairly stable.
Introduction: SARS CoV2 infection has had a major impact on renal transplant patients with a high mortality in the first months of the pandemic. Intentional reduction of immunosuppressive therapy has been postulated as one of the cornerstone in the management of the infection in the absence of targeted antiviral treatment. This has been modified according to the patient`s clinical situation and its effect on renal function or anti-HLA antibodies in the medium term has not been evaluated.
View Article and Find Full Text PDF